Apoptotic mechanism activated by blue light and cisplatinum in cutaneous squamous cell carcinoma cells
- Authors:
- Maria Fiorella Tartaglione
- María Eléxpuru Zabaleta
- Raffaella Lazzarini
- Francesco Piva
- Elena Marinelli Busilacchi
- Antonella Poloni
- Caterina Ledda
- Venerando Rapisarda
- Lory Santarelli
- Massimo Bracci
-
Affiliations: Section of Occupational Medicine, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, I-60126 Ancona, Italy, Department of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, I-60131 Ancona, Italy, Section of Hematology, Department of Clinical and Molecular Science, Polytechnic University of Marche, I-60126 Ancona, Italy, Section of Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, I-95124 Catania, Italy - Published online on: February 9, 2021 https://doi.org/10.3892/ijmm.2021.4881
- Article Number: 48
-
Copyright: © Tartaglione et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Barolet D, Roberge CJ, Auger FA, Boucher A and Germain L: Regulation of skin collagen metabolism in vitro using a pulsed 660 nm LED light source: Clinical correlation with a single-blinded study. J Invest Dermatol. 129:2751–2759. 2009. View Article : Google Scholar : PubMed/NCBI | |
Mateus C: Cutaneous squamous cell carcinoma. Rev Prat. 64:45–52. 2014.PubMed/NCBI | |
Parekh V and Seykora JT: Cutaneous squamous cell carcinoma. Clin Lab Med. 37:503–525. 2017. View Article : Google Scholar : PubMed/NCBI | |
Smoller BR: Squamous cell carcinoma: From precursor lesions to high-risk variants. Mod Pathol. 19(Suppl 2): S88–S92. 2006. View Article : Google Scholar : PubMed/NCBI | |
Palme CE, MacKay SG, Kalnins I, Morgan GJ and Veness MJ: The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg. 15:103–106. 2007. View Article : Google Scholar : PubMed/NCBI | |
Garcia-Zuazaga J and Olbricht SM: Cutaneous squamous cell carcinoma. Adv Dermatol. 24:33–57. 2008. View Article : Google Scholar : PubMed/NCBI | |
Kyrgidis A, Tzellos TG, Kechagias N, Patrikidou A, Xirou P, Kitikidou K, Bourlidou E, Vahtsevanos K and Antoniades K: Cutaneous squamous cell carcinoma (SCC) of the head and neck: Risk factors of overall and recurrence-free survival. Eur J Cancer. 46:1563–1572. 2010. View Article : Google Scholar : PubMed/NCBI | |
Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El-Naggar AK, Prieto VG, Altamirano E, Tucker SL, Strom SS, et al: Mortality risk from squamous cell skin cancer. J Clin Oncol. 23:759–765. 2005. View Article : Google Scholar : PubMed/NCBI | |
Sreedhar A, Li J and Zhao Y: Next-gen therapeutics for skin cancer: Nutraceuticals. Nutr Cancer. 70:697–709. 2018. View Article : Google Scholar : PubMed/NCBI | |
Burton KA, Ashack KA and Khachemoune A: Cutaneous squamous cell carcinoma: A review of high-risk and metastatic disease. Am J Clin Dermatol. 17:491–508. 2016. View Article : Google Scholar : PubMed/NCBI | |
Que SKT, Zwald FO and Schmults CD: Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors. J Am Acad Dermatol. 78:249–261. 2018. View Article : Google Scholar : PubMed/NCBI | |
Compagnin C, Mognato M, Celotti L, Canti G, Palumbo G and Reddi E: Cell proliferation and cell cycle alterations in oesophageal p53-mutated cancer cells treated with cisplatin in combination with photodynamic therapy. Cell Prolif. 43:262–274. 2010. View Article : Google Scholar : PubMed/NCBI | |
Bray FN, Simmons BJ, Wolfson AH and Nouri K: Acute and chronic cutaneous reactions to ionizing radiation therapy. Dermatol Ther (Heidelb). 6:185–206. 2016. View Article : Google Scholar | |
Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, et al: A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 19:68–74. 2012. View Article : Google Scholar | |
Salman M and Naseem I: Riboflavin as adjuvant with cisplatin: Study in mouse skin cancer model. Front Biosci (Elite Ed). 7:242–254. 2015. | |
Dasari S and Tchounwou PB: Cisplatin in cancer therapy: Molecular mechanisms of action. Eur J Pharmacol. 740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI | |
Mego M, Svetlovska D, Miskovska V, Obertova J, Palacka P, Rajec J, Sycova-Mila Z, Chovanec M, Rejlekova K, Zuzák P, et al: Phase II study of everolimus in refractory testicular germ cell tumors. Urol Oncol. 34:122.e17–122.e22. 2016. View Article : Google Scholar | |
Terenziani M, De Pasquale MD, Bisogno G, Biasoni D, Boldrini R, Collini P, Conte M, Dall'Igna P, Inserra A, Melchionda F, et al: Malignant testicular germ cell tumors in children and adolescents: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) protocol. Urol Oncol. 36:502.e7–502.e13. 2018. View Article : Google Scholar | |
Shi T, Jiang R, Yu J, Yang H, Tu D, Dai Z, Shen Y, Zhang Y, Cheng X, Jia H, et al: Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: A randomised, phase 2 trial. Br J Cancer. 119:12–18. 2018. View Article : Google Scholar : PubMed/NCBI | |
Tempfer CB, Giger-Pabst U, Seebacher V, Petersen M, Dogan A and Rezniczek GA: A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis. Gynecol Oncol. 150:23–30. 2018. View Article : Google Scholar : PubMed/NCBI | |
Gupta S, Maheshwari A, Parab P, Mahantshetty U, Hawaldar R, Sastri Chopra S, Kerkar R, Engineer R, Tongaonkar H, Ghosh J, et al: Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: A randomized controlled trial. J Clin Oncol. 36:1548–1555. 2018. View Article : Google Scholar : PubMed/NCBI | |
Kitagawa R, Katsumata N, Shibata T, Kamura T, Kasamatsu T, Nakanishi T, Nishimura S, Ushijima K, Takano M, Satoh T and Yoshikawa H: Paclitaxel Plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: The open-label randomized phase III trial JCOG0505. J Clin Oncol. 33:2129–2135. 2015. View Article : Google Scholar : PubMed/NCBI | |
Rosen VM, Guerra I, McCormack M, Nogueira-Rodrigues A, Sasse A, Munk VC and Shang A: Systematic review and network meta-analysis of bevacizumab plus first-line topotecan-paclitaxel or cisplatin-paclitaxel versus non-bevacizumab-containing therapies in persistent, recurrent, or metastatic cervical cancer. Int J Gynecol Cancer. 27:1237–1246. 2017. View Article : Google Scholar : PubMed/NCBI | |
Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR, Viswanathan AN and Gaffney DK: Cervical cancer: A global health crisis. Cancer. 123:2404–2412. 2017. View Article : Google Scholar : PubMed/NCBI | |
Noronha V, Joshi A, Patil VM, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, D'Cruz AK, Banavali S, et al: Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: A phase III randomized noninferiority trial. J Clin Oncol. 36:1064–1072. 2018. View Article : Google Scholar | |
Strojan P, Vermorken JB, Beitler JJ, Saba NF, Haigentz M Jr, Bossi P, Worden FP, Langendijk JA, Eisbruch A, Mendenhall WM, et al: Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review. Head Neck. 38(Suppl 1): E2151–E2158. 2016. View Article : Google Scholar | |
Szturz P, Wouters K, Kiyota N, Tahara M, Prabhash K, Noronha V, Castro A, Licitra L, Adelstein D and Vermorken JB: Weekly low-dose versus three-weekly high-dose cisplatin for concurrent chemoradiation in locoregionally advanced non-nasopharyngeal head and neck cancer: A systematic review and meta-analysis of aggregate data. Oncologist. 22:1056–1066. 2017. View Article : Google Scholar : PubMed/NCBI | |
Gridelli C, Morabito A, Cavanna L, Luciani A, Maione P, Bonanno L, Filipazzi V, Leo S, Cinieri S, Ciardiello F, et al: Cisplatin-based first-line treatment of elderly patients with advanced non-small-cell lung cancer: Joint analysis of MILES-3 and MILES-4 phase III trials. J Clin Oncol. 36:2585–2592. 2018. View Article : Google Scholar : PubMed/NCBI | |
Rossi A and Di Maio M: Platinum-based chemotherapy in advanced non-small-cell lung cancer: Optimal number of treatment cycles. Expert Rev Anticancer Ther. 16:653–660. 2016. View Article : Google Scholar : PubMed/NCBI | |
Sarin N, Engel F, Kalayda GV, Mannewitz M, Cinatl J Jr, Rothweiler F, Michaelis M, Saafan H, Ritter CA, Jaehde U and Frötschl R: Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest. PLoS One. 12:e01810812017. View Article : Google Scholar : PubMed/NCBI | |
Liu L, Fan J, Ai G, Liu J, Luo N, Li C and Cheng Z: Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells. Biol Res. 52:372019. View Article : Google Scholar : PubMed/NCBI | |
de Freitas LM, Soares CP and Fontana CR: Synergistic effect of photodynamic therapy and cisplatin: A novel approach for cervical cancer. J Photochem Photobiol B. 140:365–373. 2014. View Article : Google Scholar : PubMed/NCBI | |
Oun R, Moussa YE and Wheate NJ: The side effects of platinum-based chemotherapy drugs: A review for chemists. Dalton Trans. 47:6645–6653. 2018. View Article : Google Scholar : PubMed/NCBI | |
Crul M, van Waardenburg RC, Beijnen JH and Schellens JH: DNA-based drug interactions of cisplatin. Cancer Treat Rev. 28:291–303. 2002. View Article : Google Scholar : PubMed/NCBI | |
Fuertes MA, Alonso C and Pérez JM: Biochemical modulation of cisplatin mechanisms of action: Enhancement of antitumor activity and circumvention of drug resistance. Chem Rev. 103:645–662. 2003. View Article : Google Scholar : PubMed/NCBI | |
Oh PS and Jeong HJ: Therapeutic application of light emitting diode: Photo-oncomic approach. J Photochem Photobiol B. 192:1–7. 2019. View Article : Google Scholar : PubMed/NCBI | |
Sorbellini E, Rucco M and Rinaldi F: Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: An update. Lasers Med Sci. 33:1431–1439. 2018. View Article : Google Scholar : PubMed/NCBI | |
Brancaleon L and Moseley H: Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci. 17:173–186. 2002. View Article : Google Scholar : PubMed/NCBI | |
Ost D: Photodynamic therapy in lung cancer. A review Methods Mol Med. 75:507–526. 2003. | |
Sutedja TG and Postmus PE: Photodynamic therapy in lung cancer. A review. J Photochem Photobiol B. 36:199–204. 1996. View Article : Google Scholar : PubMed/NCBI | |
Silva JN, Filipe P, Morlière P, Mazière JC, Freitas JP, Gomes MM and Santus R: Photodynamic therapy: Dermatology and ophthalmology as main fields of current applications in clinic. Biomed Mater Eng. 18:319–327. 2008.PubMed/NCBI | |
Breskey JD, Lacey SE, Vesper BJ, Paradise WA, Radosevich JA and Colvard MD: Photodynamic therapy: Occupational hazards and preventative recommendations for clinical administration by healthcare providers. Photomed Laser Surg. 31:398–407. 2013. View Article : Google Scholar : PubMed/NCBI | |
del Olmo-Aguado S, Manso AG and Osborne NN: Light might directly affect retinal ganglion cell mitochondria to potentially influence function. Photochem Photobiol. 88:1346–1355. 2012. View Article : Google Scholar : PubMed/NCBI | |
Chui C, Hiratsuka K, Aoki A, Takeuchi Y, Abiko Y and Izumi Y: Blue LED inhibits the growth of Porphyromonas gingivalis by suppressing the expression of genes associated with DNA replication and cell division. Lasers Surg Med. 44:856–864. 2012. View Article : Google Scholar : PubMed/NCBI | |
Rybchyn MS, De Silva WGM, Sequeira VB, McCarthy BY, Dilley AV, Dixon KM, Halliday GM and Mason RS: Enhanced repair of UV-induced DNA damage by 1,25-dihydroxyvitamin D3 in skin is linked to pathways that control cellular energy. J Invest Dermatol. 138:1146–1156. 2018. View Article : Google Scholar | |
Suh SS, Lee SG, Youn UJ, Han SJ, Kim IC and Kim S: Comprehensive expression profiling and functional network analysis of porphyra-334, one mycosporine-like amino acid (MAA), in human keratinocyte exposed with UV-radiation. Mar Drugs. 15:1962017. View Article : Google Scholar : | |
Muhammad S, Qasid SH, Rehman S and Rai AB: Visible light communication applications in healthcare. Technol Health Care. 24:135–138. 2016. View Article : Google Scholar | |
Tsibadze A, Chikvaidze E, Katsitadze A, Kvachadze I, Tskhvediani N and Chikviladze A: Visible light and human skin (Review). Georgian Med News. 46–53. 2015.In Russian. | |
Gegotek A, Atalay S, Domingues P and Skrzydlewska E: The differences in the proteome profile of cannabidiol-treated skin fibroblasts following UVA or UVB irradiation in 2D and 3D cell cultures. Cells. 8:9952019. View Article : Google Scholar : | |
Zhang C, Yuchi H, Sun L, Zhou X and Lin J: Human amnion-derived mesenchymal stem cells protect against UVA irradiation-induced human dermal fibroblast senescence, in vitro. Mol Med Rep. 16:2016–2022. 2017. View Article : Google Scholar : PubMed/NCBI | |
Patel AD, Rotenberg S, Messer RL, Wataha JC, Ogbureke KU, McCloud VV, Lockwood P, Hsu S and Lewis JB: Blue light activates phase 2 response proteins and slows growth of a431 epidermoid carcinoma xenografts. Anticancer Res. 34:6305–6313. 2014.PubMed/NCBI | |
Niu T, Tian Y, Wang G, Guo G, Tong Y and Shi Y: Inhibition of ROS-NF-κB-dependent autophagy enhances hypocrellin A united LED red light-induced apoptosis in squamous carcinoma A431 cells. Cell Signal. 69:1095502020. View Article : Google Scholar | |
Meulemans J, Delaere P and Vander Poorten V: Photodynamic therapy in head and neck cancer: Indications, outcomes, and future prospects. Curr Opin Otolaryngol Head Neck Surg. 27:136–141. 2019. View Article : Google Scholar : PubMed/NCBI | |
Kerr C, Adhikary G, Grun D, George N and Eckert RL: Combination cisplatin and sulforaphane treatment reduces proliferation, invasion, and tumor formation in epidermal squamous cell carcinoma. Mol Carcinog. 57:3–11. 2018. View Article : Google Scholar | |
Hwang H, Biswas R, Chung PS and Ahn JC: Modulation of EGFR and ROS induced cytochrome c release by combination of photodynamic therapy and carboplatin in human cultured head and neck cancer cells and tumor xenograft in nude mice. J Photochem Photobiol B. 128:70–77. 2013. View Article : Google Scholar : PubMed/NCBI | |
Zhang X, Liu X, Kang S, Liu C and Hao Y: Resveratrol enhances the effects of ALA-PDT on skin squamous cells A431 through p38/MAPK signaling pathway. Cancer Biomark. 21:797–803. 2018. View Article : Google Scholar | |
Tampucci S, Carpi S, Digiacomo M, Polini B, Fogli S, Burgalassi S, Macchia M, Nieri P, Manera C and Monti D: Diclofenac-derived hybrids for treatment of actinic keratosis and squamous cell carcinoma. Molecules. 24:17932019. View Article : Google Scholar : | |
Carbone C, Martins-Gomes C, Pepe V, Silva AM, Musumeci T, Puglisi G, Furneri PM and Souto EB: Repurposing itraconazole to the benefit of skin cancer treatment: A combined azole-DDAB nanoencapsulation strategy. Colloids Surf B Biointerfaces. 167:337–344. 2018. View Article : Google Scholar : PubMed/NCBI | |
Chen H, Pan J, Zhang L, Chen L, Qi H, Zhong M, Shi X, Du J and Li Q: Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways. Eur J Pharmacol. 825:133–142. 2018. View Article : Google Scholar : PubMed/NCBI | |
Ou C, Liu H, Ding Z and Zhou L: Chloroquine promotes gefitinib-induced apoptosis by inhibiting protective autophagy in cutaneous squamous cell carcinoma. Mol Med Rep. 20:4855–4866. 2019.PubMed/NCBI | |
Fusenig NE and Boukamp P: Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol Carcinog. 23:144–158. 1998. View Article : Google Scholar : PubMed/NCBI | |
Colombo I, Sangiovanni E, Maggio R, Mattozzi C, Zava S, Corbett Y, Fumagalli M, Carlino C, Corsetto PA, Scaccabarozzi D, et al: HaCaT cells as a reliable in vitro differentiation model to dissect the inflammatory/repair response of human keratinocytes. Mediators Inflamm. 2017:74356212017. View Article : Google Scholar | |
Cordero RR, Damiani A, Seckmeyer G, Jorquera J, Caballero M, Rowe P, Ferrer J, Mubarak R, Carrasco J, Rondanelli R, et al: The solar spectrum in the atacama det. Sci Rep. 6:224572016. View Article : Google Scholar | |
Faurschou A, Gniadecki R, Calay D and Wulf HC: TNF-alpha impairs the S-G2/M cell cycle checkpoint and cyclobutane pyrimidine dimer repair in premalignant skin cells: Role of the PI3K-Akt pathway. J Invest Dermatol. 128:2069–2077. 2008. View Article : Google Scholar : PubMed/NCBI | |
Schug ZT, Gonzalvez F, Houtkooper RH, Vaz FM and Gottlieb E: BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane. Cell Death Differ. 18:538–548. 2011. View Article : Google Scholar : | |
Huang C and Yu Y: Synergistic cytotoxicity of β-elemene and cisplatin in gingival squamous cell carcinoma by inhibition of STAT3 signaling pathway. Med Sci Monit. 23:1507–1513. 2017. View Article : Google Scholar : PubMed/NCBI | |
Tao JX, Zhou WC and Zhu XG: Mitochondria as potential targets and initiators of the blue light hazard to the retina. Oxid Med Cell Longev. 2019:64353642019. View Article : Google Scholar : PubMed/NCBI | |
Hientz K, Mohr A, Bhakta-Guha D and Efferth T: The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget. 8:8921–8946. 2017. View Article : Google Scholar : | |
Batchelor E and Loewer A: Recent progress and open challenges in modeling p53 dynamics in single cells. Curr Opin Syst Biol. 3:54–59. 2017. View Article : Google Scholar : PubMed/NCBI | |
Batchelor E, Loewer A, Mock C and Lahav G: Stimulus-dependent dynamics of p53 in single cells. Mol Syst Biol. 7:4882011. View Article : Google Scholar : PubMed/NCBI | |
Paek AL, Liu JC, Loewer A, Forrester WC and Lahav G: Cell-to-cell variation in p53 dynamics leads to fractional killing. Cell. 165:631–642. 2016. View Article : Google Scholar : PubMed/NCBI | |
Bowen AR, Hanks AN, Allen SM, Alexander A, Diedrich MJ and Grossman D: Apoptosis regulators and responses in human melanocytic and keratinocytic cells. J Invest Dermatol. 120:48–55. 2003. View Article : Google Scholar : PubMed/NCBI | |
Laubach V, Kaufmann R, Bernd A, Kippenberger S and Zöller N: Extrinsic or intrinsic apoptosis by curcumin and light: Still a mystery. Int J Mol Sci. 20:9052019. View Article : Google Scholar : | |
Cives M, Mannavola F, Lospalluti L, Sergi MC, Cazzato G, Filoni E, Cavallo F, Giudice G, Stucci LS, Porta C and Tucci M: Non-melanoma skin cancers: Biological and clinical features. Int J Mol Sci. 21:53942020. View Article : Google Scholar : | |
Gargiulo M, Papa A, Capasso P, Moio M, Cubicciotti E and Parascandolo S: Electrochemotherapy for non-melanoma head and neck cancers: Clinical outcomes in 25 patients. Ann Surg. 255:1158–1164. 2012. View Article : Google Scholar : PubMed/NCBI | |
Goggins CA and Khachemoune A: The use of electrochemotherapy in combination with immunotherapy in the treatment of metastatic melanoma: A focused review. Int J Dermatol. 58:865–870. 2019. View Article : Google Scholar | |
Montuori M, Santurro L, Feliziani A, DE Sanctis F, Ricciardi E, Gaudio D, Campione E, Bianchi L, Silvi MB and Rossi P: Electrochemotherapy for basocellular and squamocellular head and neck cancer: preliminary experience in day surgery unit. G Ital Dermatol Venereol. 153:19–25. 2018. | |
Grzelak A, Rychlik B and Bartosz G: Light-dependent generation of reactive oxygen species in cell culture media. Free Radic Biol Med. 30:1418–1425. 2001. View Article : Google Scholar : PubMed/NCBI | |
Stockley JH, Evans K, Matthey M, Volbracht K, Agathou S, Mukanowa J, Burrone J and Káradóttir RT: Surpassing light-induced cell damage in vitro with novel cell culture media. Sci Rep. 7:8492017. View Article : Google Scholar : PubMed/NCBI |